Is BRCA2 p.Asp2110= (c.6330T>C) pathogenic?

BRCA2 p.Asp2110= (c.6330T>C) is classified Likely benign in BRCA2 (ClinVar, Multiple submitters, 2 submitters; last evaluated 2022-08-21). Absent from gnomAD v4.1; Associated with hereditary breast ovarian cancer syndrome.

What condition is associated with BRCA2 p.Asp2110= (c.6330T>C)?

BRCA2 p.Asp2110= (c.6330T>C) is associated with hereditary breast ovarian cancer syndrome, hereditary neoplastic syndrome (ClinVar).

How common is BRCA2 p.Asp2110= (c.6330T>C) in the general population?

BRCA2 p.Asp2110= (c.6330T>C) is absent from gnomAD v4.1 (gnomAD).

How is Hereditary breast and/or ovarian cancer syndrome inherited?

Typically Autosomal dominant (Orphanet). A genetic counselor can assess individual risk for a family.

BRCA2 p.Asp2110=

c.6330T>C · rs1593908284 · VCV742829

Likely benign Multiple submitters

Classification

Likely benign

ClinVar

Review

Multiple submitters ★★☆☆

ClinVar · 2 submitters

gnomAD v4.1

Absent

absent from gnomAD v4.1

Conditions

hereditary breast ovarian cancer syndrome

Computational evidence

Protein change
Missense predictors do not apply to this variant type; conservation carries the signal.
Splicing
SpliceAI	—	not assessed · no allele here is in the release
Constraint at this position
Conservation	phyloP 0.19	GERP -3.5, phastCons 0.02
Overall
CADD	1.246	PHRED · no single calibrated threshold — expert panels disagree

Population frequency

gnomAD v4.1 · exomes + genomes

Absent from gnomAD v4.1. Not observed in any sequenced alleles — a rarity signal (ACMG PM2-supporting), not evidence of pathogenicity on its own.

Variant & gene context

Gene: BRCA2
Protein: p.Asp2110=
Coding: c.6330T>C
MANE Select: NM_000059
dbSNP: rs1593908284
Type: single nucleotide variant
Location: chr13:32340685 (GRCh38)
Gene constraint: LOEUF 0.803 · pLI <0.01 · ClinGen HI 3/3 (gnomAD)

Full BRCA2 gene report on Sugi Atlas → Gene function, pathways, protein structure, interactions & more

Disease context

hereditary breast ovarian cancer syndrome — disease report on Sugi Atlas → Associated genes, phenotypes, clinical trials & treatments

Also linked: hereditary neoplastic syndrome

For Hereditary breast and/or ovarian cancer syndrome (Orphanet):

Inheritance: Autosomal dominant
Onset: Adult, Elderly

Similar variants

BRCA2 p.Asp2110Asn Uncertain significance ★★ ⚠ same residue
BRCA2 p.Asp2110Ala Conflicting classifications of pathogenicity ★ ⚠ same residue
BRCA2 p.Asp2110Gly Conflicting classifications of pathogenicity ★ same residue
BRCA2 p.Asp2110His Conflicting classifications of pathogenicity ★ ⚠ same residue
BRCA2 p.Asp2110Val Conflicting classifications of pathogenicity ★ ⚠ same residue
BRCA2 p.Asp2110delinsValTer Pathogenic ★★ same residue
BRCA2 p.Asp2110Ter Pathogenic ★★ same residue
BRCA2 p.Asp2110del Uncertain significance ★★ same residue

Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →

Cite Sugi Variant

Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/brca2-p-asp2110 (accessed [today's date]).

Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown